sahr_mahran

sahar abo el fetooh

Assistant Professor - رئيس وحدة المناعة بقسم التحاليل الطبية

Faculty of medicine

Address: قسم الباثولوجيا الاكلينكية-كليه طب سوهاج

0

Like
9 9 0 8 2 1 115 355
93

Newly Added
  • Courses 9
  • Course Supplements 9
  • Courses Tasks 0
  • Publications 8
  • Office hours 2
  • Announcements 1
  • File uploaded 16
  • Downloaded Times 1

I am Dr/sahar fetooh ,Assistant professor of chemical and the head of immunology department 

محاضرة الفرقه الخامسة

2018-10-10 17:34:24
محاضرة الفرقه الخامسة
يوم الاثنين 20/5/2018 Antigen & Antibody Reaction ساقوم بالقاء محاضرة بعنوان Read more

Show More Announcements

Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt.

2018-10-01 00:32:01 | Keywords Characteristics,
Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt.
ABSTRACT AIM: To investigate the prevalence and virological characteristics of occult hepatitis B virus (HBV) infections in patients with hematological malignancies in South Egypt. METHODS: Serum samples were collected from 165 patients with hematological malignancies to monitor titers of HBV DNA, hepatitis B surface antigen (HBsAg), and antibodies to HBV core (anti-HBc) and surface antigens. Serum samples negative for HBsAg ... Read more

T cell Immunoglobulin Mucin-3 (TIM-3) Expression on Peripheral Blood Lymphocytes in Chronic Hepatitis Virus C Infection

2018-10-01 00:10:43 | Keywords T cell Immunoglobulin,
T cell Immunoglobulin Mucin-3 (TIM-3) Expression on Peripheral Blood Lymphocytes in Chronic Hepatitis Virus C Infection
ABSTRACT Introduction: T cell IMMUNOGLOBULIN MUCIN-3 (TIM-3) TIM-3 acts as a negative regulator of (T helper-1)Th1/ (T Cytotoxic-1)Tc1 cell function by triggering cell death upon interaction with its ligand Galectin-9, a feature observed in CHRONIC viral diseases. Objective: To demonstrate the level of expression of TIM-3 on Peripheral Blood Mononuclear cells (PBCs) in cases of chronic HCV as a number ... Read more

Serum interleukin-18 and interleukin-10 levels in systemic lupus erythematosus: correlation with SLEDAI score and disease activity parameters

2018-10-01 00:48:13 | Keywords Serum interleukin-18,
Serum interleukin-18 and interleukin-10 levels in systemic lupus erythematosus: correlation with SLEDAI score and disease activity parameters
AIM The aim of the study was to assess serum levels of interleukin (IL)-18 and IL-10 in systemic lupus erythematosus (SLE) patients and their relationship with disease activity. PATIENTS AND METHODS Thirty patients with SLE and 20 healthy controls were investigated in this study. The serum IL-18 and IL-10 levels were determined using enzyme-linked immunosorbent assay and their correlations with ... Read more

Genetic Polymorphism of Angiotensin Converting Enzyme and the Angiotensin II Type1 Receptor as Risk Factors in Patients with Chronic Kidney Disease

2018-09-30 23:55:23 | Keywords Genetic Polymorphism,
Genetic Polymorphism of Angiotensin Converting Enzyme and the Angiotensin II Type1 Receptor as Risk Factors in Patients with Chronic Kidney Disease
Abstract: Background: The rennin angiotensin system (RAS) is central to the pathogenesis of hypertension, cardiovascular disease and kidney disease. Angiotensin converting enzyme (ACE) and angiotensin II type 1 receptor (AT1R) are two of the main components of the RAS. The genetic polymorphisms of these key components provide a basis for studying the relationship between genetic variants and the development of ... Read more

Incidence and characteristics of HBV reactivation in hematological malignant patients

2018-09-30 23:30:41 | Keywords Incidence and characteristics,
Incidence and characteristics of HBV reactivation in hematological malignant patients
Abstract AIM: To investigate characteristics of hepatitis B virus (HBV) implicated in HBV reactivation in patients with hematological malignancies receiving immunosuppressive therapy. METHODS: Serum samples were collected from 53 patients with hematological malignancies negative for hepatitis B surface antigen (HBsAg) before the start of and throughout the chemotherapy course. HBV reactivation was diagnosed when the HBsAg status changed from negative ... Read more

Show More Posts